Psychopathy is a disorder characterized by lack of empathy and remorse, antisocial behavior, increased tendencies towards aggression and anger, and blunted anticipatory fear.
Articles
Senators Vote To Expand Medical Marijuana Access For Military Veterans In Key Committee
A powerful Senate committee on Wednesday approved an amendment that’s meant to promote military veterans’ access to medical marijuana by allowing doctors at the U.S. Department of Veterans Affairs (VA) to issue cannabis recommendations in legal states.
Psychedelics Decriminalization Advancing In Three More Cities, Spanning From Coast To Coast
From Massachusetts to California, advocates are actively making new strides to reform local laws governing psychedelics like psilocybin and ayahuasca—building on a national movement that has already seen numerous cities decriminalize entheogenic substances.
UK to Study Using Cannabis-Based Medicine to Treat Brain Tumors
The United Kingdom National Health Service and Brain Tumour Charity are partnering on research to determine whether cannabis-based medicine Sativex paired with chemotherapy medication temozolomide can treat glioblastoma, a recurrent brain tumor, the Guardian reports. Once underway, it will be the first such study of its kind in the world.
Texas Nurses Deliver CBD For Holistic Approach to Healthcare
Gina Hogan and Alisha Northern, two nurses with decades of medical experience, launched TX Canna RN together.
Canada’s Mohawk Council of Kahnawà:ke Signs Cannabis Agreement with Health Canada
The Mohawk Council of Kahnawà:ke has signed a Memorandum of Understanding with Health Canada to establish its own laws and regulations for the production and sale of cannabis within the MCK territory.
Maryland Cannabis Legalization Referendum Likely for 2022 Ballots
Maryland House Speaker Adrienne A. Jones has indicated that she will support a cannabis legalization referendum on 2022 ballots and announced a plan to create a cannabis workgroup to lay the framework for the industry if the reforms are approved by voters, Maryland Matters reports. Jones said the House “will pass legislation early next year” to put the question to voters.
Louisiana Ends Jail Time for Small Amounts of Cannabis
Louisiana ended the punishment of jail time for possession of small amounts of recreational cannabis, which took effect Sunday.
Study: HIV Patients Who Use Cannabis Daily See Lower Neuroinflammation
HIV-positive patients who consume cannabis daily have lower levels of neuroinflammation than non-cannabis consuming HIV-positive patients, according to a study.
DEA Says Cancer Patients’ Request For Medical Psilocybin Could Fuel Illegal Drug Market
The U.S. Drug Enforcement Administration is asking a federal appeals court to throw out a lawsuit aimed at clearing a path to the therapeutic use of psilocybin, the main psychoactive compound in psychedelic mushrooms—arguing that allowing limited medical access could boost the illegal drug trade.
California Lawmakers Approve Bill To Legalize Psychedelics Possession In Committee
A California Assembly committee on Tuesday approved a Senate-passed bill to legalize possession of psychedelics, clearing its first major hurdle in the chamber.
Ayahuasca use associated with greatly improved anxiety and depression symptoms in large international study
Despite their illegality and a tendency among the media and politicians to demonize their use, psychedelics have been shown to have transformative effects on individuals suffering from mental health problems, including depression and anxiety.
Oregon State Board Says Psilocybin Is Effective At Treating Certain Mental Health Condition
An Oregon review panel established under the state’s voter-approved therapeutic psilocybin legalization initiative has released a report stating that the psychedelic holds significant medical value for a number of mental health conditions.
Will The Covid-19 Pandemic Be A Turning Point For Psychedelic Medicine?
The Mental Health Crisis has been ignored for decades. Covid-19 has made this mental health catastrophe much worse -- and people are now starting to notice.
atai Life Sciences launches InnarisBio, in partnership with the University of Queensland, with the aim to develop a more effective nose-to-brain delivery method for atai’s platform of mental health therapeutic programs
Atai Life Sciences announces the launch of a new intranasal drug delivery system, InnarisBio, based on sol-gel technology.